Neoplasia

Article	Citations
UALCAN: An update to the integrated cancer data analysis platform	973
ONC201 and imipridones: Anti-cancer compounds with clinical efficacy	101
Development and prevalence of castration-resistant prostate cancer subtypes	83
ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma	82
STAT3 as a mediator of oncogenic cellular metabolism: Pathogenic and therapeutic implications	58
Glycolysis-induced drug resistance in tumors—A response to danger signals?	58
Exosomal lncRNA NEAT1 from cancer-associated fibroblasts facilitates endometrial cancer progression via miR-26a/b-5p-mediated STAT3/YKL-40 signaling pathway	52
SalvGlandDx – a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targets	48
The forces driving cancer extracellular vesicle secretion	48
Evaluating patient-specific neoadjuvant regimens for breast cancer via a mathematical model constrained by quantitative magnetic resonance imaging data	43
Rosmarinic acid represses colitis-associated colon cancer: A pivotal involvement of the TLR4-mediated NF-κB-STAT3 axis	43
Tumor necrosis factor in lung cancer: Complex roles in biology and resistance to treatment	41
Breast cancers, mammary stem cells, and cancer stem cells, characteristics, and hypotheses	39
Pediatric low-grade glioma: Targeted therapeutics and clinical trials in the molecular era	36
Short chain fatty acids delay the development of hepatocellular carcinoma in HBx transgenic mice	36
Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine	35
MiR-944/CISH mediated inflammation via STAT3 is involved in oral cancer malignance by cigarette smoking	34
Quantifying ADC bystander payload penetration with cellular resolution using pharmacodynamic mapping	34
The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science	33
Trop‐2 cleavage by ADAM10 is an activator switch for cancer growth and metastasis	33
Predicting patient-specific response to adaptive therapy in metastatic castration-resistant prostate cancer using prostate-specific antigen dynamics	33
Bone marrow mesenchymal stem cells interact with head and neck squamous cell carcinoma cells to promote cancer progression and drug resistance	30
Cholesterol and saturated fatty acids synergistically promote the malignant progression of prostate cancer	29
Endogenous hydrogen sulfide regulates xCT stability through persulfidation of OTUB1 at cysteine 91 in colon cancer cells	29
Opioids drive breast cancer metastasis through the δ-opioid receptor and oncogenic STAT3	28

Ultrasound-mediated disruption of the blood tumor barrier for improved therapeutic delivery	27
EZH2i EPZ-6438 and HDACi vorinostat synergize with ONC201/TIC10 to activate integrated stress response, DR5, reduce H3K27 methylation, ClpX and promote apoptosis of multiple tumor types including DIPG	27
Spatiotemporal trends of the global burden of melanoma in 204 countries and territories from 1990 to 2019: Results from the 2019 global burden of disease study	26
Myeloid-derived suppressor cells promote tumor growth and sorafenib resistance by inducing FGF1 upregulation and fibrosis	25
Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer	25
Copy number variation in triple negative breast cancer samples associated with lymph node metastasis	25
Mathematical modeling of radiotherapy and its impact on tumor interactions with the immune system	24
Composition of gastrointestinal microbiota in association with treatment response in individuals with metastatic castrate resistant prostate cancer progressing on enzalutamide and initiating treatment	24
Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis	24
Hypoxia induces docetaxel resistance in triple-negative breast cancer via the HIF-1α/miR-494/Survivin signaling pathway	23
Microbiota-driven mechanisms at different stages of cancer development	23
Estrogen-induced hypomethylation and overexpression of YAP1 facilitate breast cancer cell growth and survival	23
Tumor-immune ecosystem dynamics define an individual Radiation Immune Score to predict pan-cancer radiocurability	23
Enterococcus faecalis promotes a migratory and invasive phenotype in colon cancer cells	23
Diet-microbiome interactions in cancer treatment: Opportunities and challenges for precision nutrition in cancer	22
Perturbations of cancer cell metabolism by the antidiabetic drug canagliflozin	22
Noninvasive multiparametric characterization of mammary tumors with transmission-reflection optoacoustic ultrasound	22
A systematic review of microbiome-derived biomarkers for early colorectal cancer detection	22
Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1)	21
Fusobacterium nucleatum stimulates cell proliferation and promotes PD-L1 expression via IFIT1-related signal in colorectal cancer	21
A systemic review of the role of enterotoxic Bacteroides fragilis in colorectal cancer	21
PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of β-catenin and PD-L1	21
Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenström macroglobulinemia	20
Discovery of a new inhibitor targeting PD-L1 for cancer immunotherapy	20
Implications of the microbiome in the development and treatment of pancreatic cancer: Thinking outside of the box by looking inside the gut	20
Panobinostat enhances olaparib efficacy by modifying expression of homologous recombination repair and immune transcripts in ovarian cancer	20
mTORC2-mediated direct phosphorylation regulates YAP activity promoting glioblastoma growth and invasive characteristics	20
P53-independent partial restoration of the p53 pathway in tumors with mutated p53 through ATF4 transcriptional modulation by ERK1/2 and CDK9	20
The paradox of radiation and T cells in tumors	20
Synergistic effect of Chloroquine and Panobinostat in ovarian cancer through induction of DNA damage and inhibition of DNA repair	19
Non-melanoma skin cancers: physio-pathology and role of lipid delivery systems in new chemotherapeutic treatments	19
Abscisic acid regulates dormancy of prostate cancer disseminated tumor cells in the bone marrow	19
The interleukin-1 axis and the tumor immune microenvironment in pancreatic ductal adenocarcinoma	18
High expression of SCHLAP1 in primary prostate cancer is an independent predictor of biochemical recurrence, despite substantial heterogeneity	18
Cancer: A turbulence problem	17
SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway	17
A cohesive look at leukemogenesis: The cohesin complex and other driving mutations in AML	17
Chromobox 4 facilitates tumorigenesis of lung adenocarcinoma through the Wnt/β-catenin pathway	16
Carcinogenesis induced by space radiation: A systematic review	16
CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation	16
Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [18F]DASA-23, a non-invasive probe of pyruvate kinase M2 (PKM2) expression	16
Targeting methyltransferase PRMT5 retards the carcinogenesis and metastasis of HNSCC via epigenetically inhibiting Twist1 transcription	15
The p53-inducible CLDN7 regulates colorectal tumorigenesis and has prognostic significance	15
Targeting hypoxia regulated sodium driven bicarbonate transporters reduces triple negative breast cancer metastasis	15
Unsupervised machine learning using K-means identifies radiomic subgroups of pediatric low-grade gliomas that correlate with key molecular markers	15
Locoregional CAR T cells for children with CNS tumors: Clinical procedure and catheter safety	15
Breast cancer cell debris diminishes therapeutic efficacy through heme oxygenase-1-mediated inactivation of M1-like tumor-associated macrophages	15
c-Myb interferes with inflammatory IL1α-NF-κB pathway in breast cancer cells	15
Lysyl hydroxylase 2-induced collagen cross-link switching promotes metastasis in head and neck squamous cell carcinomas	15
Hypoxia theranostics of a human prostate cancer xenograft and the resulting effects on the tumor microenvironment	15

Targeting interleukin 4 receptor alpha on tumor-associated macrophages reduces the pro-tumor macrophage phenotype	14
Targeting GRP78 suppresses oncogenic KRAS protein expression and reduces viability of cancer cells bearing various KRAS mutations	14
Circ_0089823 reinforces malignant behaviors of non-small cell lung cancer by acting as a sponge for microRNAs targeting SOX4,	14
Synergizing radiotherapy and immunotherapy: Current challenges and strategies for optimization	14
Injured tissues favor cancer cell implantation via fibrin deposits on scar zones	14
A glypican-1-targeted antibody-drug conjugate exhibits potent tumor growth inhibition in glypican-1-positive pancreatic cancer and esophageal squamous cell carcinoma	14
Past, present and future of Focused Ultrasound as an adjunct or complement to DIPG/DMG therapy: A consensus of the 2021 FUSF DIPG meeting	14
Inhibition of fibronectin accumulation suppresses tumor growth	13
Nucleostemin upregulation and STAT3 activation as early events in oral epithelial dysplasia progression to squamous cell carcinoma	13
Nuclear morphology predicts cell survival to cisplatin chemotherapy	13
Chloride intracellular channel protein 2 is secreted and inhibits MMP14 activity, while preventing tumor cell invasion and metastasis	13
Resensitising proteasome inhibitor-resistant myeloma with sphingosine kinase 2 inhibition	13
From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy	13
The breast tissue microbiome, stroma, immune cells and breast cancer	13
Molecular homology between canine spontaneous oral squamous cell carcinomas and human head-and-neck squamous cell carcinomas reveals disease drivers and therapeutic vulnerabilities	13
Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patients	13
STAMBP promotes lung adenocarcinoma metastasis by regulating the EGFR/MAPK signaling pathway	13
Cross-talk among MEN1, p53 and Notch regulates the proliferation of pancreatic neuroendocrine tumor cells by modulating INSM1 expression and subcellular localization	13
Inhibition of DNA-PK may improve response to neoadjuvant chemoradiotherapy in rectal cancer	12
Eucannabinolide, a novel sesquiterpene lactone, suppresses the growth, metastasis and BCSCS-like traits of TNBC via inactivation of STAT3	12
Proprotein convertase subtilisin/kexin Type 9 is required for Ahnak-mediated metastasis of melanoma into lung epithelial cells	12
The anti-B7-H4 checkpoint synergizes trastuzumab treatment to promote phagocytosis and eradicate breast cancer	12
Spectroscopic investigation of radiation-induced reoxygenation in radiation-resistant tumors	12
Targeted and explorative profiling of kallikrein proteases and global proteome biology of pancreatic ductal adenocarcinoma, chronic pancreatitis, and normal pancreas highlights disease-specific proteo	12
Suppression of ER-stress induction of GRP78 as an anti-neoplastic mechanism of the cardiac glycoside Lanatoside C in pancreatic cancer	12
Gut microbiota-derived short-chain fatty acids promote prostate cancer progression via inducing cancer cell autophagy and M2 macrophage polarization	12
Noninvasive optoacoustic microangiography reveals dose and size dependency of radiation-induced deep tumor vasculature remodeling	12
SUMOylation is essential for Sirt2 tumor-suppressor function in neuroblastoma	12
Understanding the roles of N6-methyladenosine writers, readers and erasers in breast cancer	12
PEGPH20, a PEGylated human hyaluronidase, induces radiosensitization by reoxygenation in pancreatic cancer xenografts. A molecular imaging study	11
miR-524-5p reduces the progression of the BRAF inhibitor-resistant melanoma	11
Combining selinexor with alisertib to target the p53 pathway in neuroblastoma	11
The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53	11
Hepatocellular carcinoma-derived FOXO1 inhibits tumor progression by suppressing IL-6 secretion from macrophages	11
Identification of disease-promoting stromal components by comparative proteomic and transcriptomic profiling of canine mammary tumors using laser-capture microdissected FFPE tissue	11
Proteome biology of primary colorectal carcinoma and corresponding liver metastases	11
High dose acetaminophen inhibits STAT3 and has free radical independent anti-cancer stem cell activity	11
PAD4-dependent citrullination of nuclear translocation of GSK3β promotes colorectal cancer progression via the degradation of nuclear CDKN1A	11
Smac mimetics and TRAIL cooperate to induce MLKL-dependent necroptosis in Burkitt's lymphoma cell lines	10
Reduction in mitochondrial oxidative stress mediates hypoxia-induced resistance to cisplatin in human transitional cell carcinoma cells	10
Epigenome-wide DNA methylation profiling of portal vein tumor thrombosis (PVTT) tissues in hepatocellular carcinoma patients	10
Therapeutic avenues for targeting treatment challenges of diffuse midline gliomas	10
CBP-mediated Wnt3a/β-catenin signaling promotes cervical oncogenesis initiated by Piwil2	10
Global molecular alterations involving recurrence or progression of pediatric brain tumors	10
Role of heparanase 2 (Hpa2) in gastric cancer	10
Upregulation of HIF1-α via an NF-κB/COX2 pathway confers proliferative dominance of HER2-negative ductal carcinoma in situ cells in response to inflammatory stimuli	10
Therapeutic effiacy of T cells expressing chimeric antigen receptor derived from a mesothelin-specific scFv in orthotopic human pancreatic cancer animal models	10
Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5	10
Tumor cell endogenous HIF-1α activity induces aberrant angiogenesis and interacts with TRAF6 pathway required for colorectal cancer development	10
Exome sequencing identifies frequent genomic loss of TET1 in IDH-wild-type glioblastoma	10
SHC014748M, a novel selective inhi-bitor of PI3Kδ, demonstrates promising preclinical antitumor activity in B cell lymphomas and chronic lymphocytic leukemia	10
Bacterial translocation and barrier dysfunction enhance colonic tumorigenesis	10
Suppression of CCDC6 sensitizes tumor to oncolytic virus M1	9
Current studies and future directions for medulloblastoma: A review from the pacific pediatric neuro-oncology consortium (PNOC) disease working group	9
Differentiated embryonic chondrocyte expressed gene-1 (DEC1) enhances the development of colorectal cancer with an involvement of the STAT3 signaling	9
Ovulation sources coagulation protease cascade and hepatocyte growth factor to support physiological growth and malignant transformation	9
DNA polymerase β deficiency promotes the occurrence of esophageal precancerous lesions in mice	9
Microbial mechanisms to improve immune checkpoint blockade responsiveness	9
In vivo two-photon characterization of tumor-associated macrophages and microglia (TAM/M) and CX3CR1 during different steps of brain metastasis formation from lung cancer	9
PAX8 modulates the tumor microenvironment of high grade serous ovarian cancer through changes in the secretome	9
miR-138-5p induces aggressive traits by targeting Trp53 expression in murine melanoma cells, and correlates with poor prognosis of melanoma patients	9
Loss of Fbxw7 triggers mammary tumorigenesis associated with E2F/c-Myc activation and Trp53 mutation	9
Spatial distribution of immune checkpoint proteins in histological subtypes of lung adenocarcinoma	9
Regulation of growth, invasion and metabolism of breast ductal carcinoma through CCL2/CCR2 signaling interactions with MET receptor tyrosine kinases	9
Mcl-1 levels critically impact the sensitivities of human colorectal cancer cells to APG-1252-M1, a novel Bcl-2/Bcl-XL dual inhibitor that induces Bax-dependent apoptosis	9
The microbial genotoxin colibactin exacerbates mismatch repair mutations in colorectal tumors	9
Hedgehog/GLI1 Transcriptionally Regulates FANCD2 in Ovarian Tumor Cells: Its Inhibition Induces HR-Deficiency and Synergistic Lethality with PARP Inhibition.	9
Radiation-induced lymphopenia does not impact treatment efficacy in a mouse tumor model	9
STAT3 contributes to cisplatin resistance, modulating EMT markers, and the mTOR signaling in lung adenocarcinoma	9
Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? – A preclinical assessment in vitro and in vivo	9
Myelodysplastic syndromes: Biological and therapeutic consequences of the evolving molecular aberrations landscape	8
p85β alters response to EGFR inhibitor in ovarian cancer through p38 MAPK-mediated regulation of DNA repair	8
Patient-specific molecular response dynamics can predict the possibility of relapse during the second treatment-free remission attempt in chronic myelogenous leukemia	8
Myeloperoxidase exerts anti-tumor activity in glioma after radiotherapy	8
Antibiotic treatment targeting gram negative bacteria prevents neratinib-induced diarrhea in rats	8
Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor	8
Lung cancer lesion detection in histopathology images using graph‐based sparse PCA network	8
Naproxen inhibits spontaneous lung adenocarcinoma formation in KrasG12V mice	8
Genomic landscape of metastatic lung adenocarcinomas from large-scale clinical sequencing	8
Cell competition, cooperation, and cancer	8

Pharmacological inhibition of the SKP2/p300 signaling axis restricts castration-resistant prostate cancer	8
Tumor necrosis factor receptor signaling modulates carcinogenesis in a mouse model of breast cancer	8
Niche-derived soluble DLK1 promotes glioma growth	8
mTORC2 regulates ribonucleotide reductase to promote DNA replication and gemcitabine resistance in non-small cell lung cancer	7
Pioneering models of pediatric brain tumors	7
A G-quadruplex stabilizer, CX-5461 combined with two immune checkpoint inhibitors enhances in vivo therapeutic efficacy by increasing PD-L1 expression in colorectal cancer	7
Primary central nervous system germ cell tumors in children and young adults: A review of controversies in diagnostic and treatment approach	7
Optical scattering as an early marker of apoptosis during chemotherapy and antiangiogenic therapy in murine models of prostate and breast cancer	7
SOMCL-19-133, a novel, selective, and orally available inhibitor of NEDD8-activating enzyme (NAE) for cancer therapy	7
Cyst fluid metabolites distinguish malignant from benign pancreatic cysts	7
Phenotypic and molecular states of IDH1 mutation-induced CD24-positive glioma stem-like cells	7
Role of AMPK and Akt in triple negative breast cancer lung colonization	7
FOXM1 increases hTERT protein stability and indicates poor prognosis in gastric cancer	7
The renal clear cell carcinoma immune landscape	7
Overcoming ABCB1-mediated multidrug resistance by transcription factor BHLHE40	7
The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells	7
U-RT1 – A new model for Richter transformation	7
PRMT1 methylates METTL14 to modulate its oncogenic function	7
Therapeutic significance of ARID1A mutation in bladder cancer	7
Strength and duration of GIPC-dependent signaling networks as determinants in cancer	7
HDAC6 promotes aggressive development of liver cancer by improving egfr mRNA stability	6
The promise of metabolic imaging in diffuse midline glioma	6
Whole-chromosome arm acquired uniparental disomy in cancer development is a consequence of isochromosome formation	6
Identification of novel targets of miR-622 in hepatocellular carcinoma reveals common regulation of cooperating genes and outlines the oncogenic role of zinc finger CCHC-type containing 11	6
Copy number alteration of the interferon gene cluster in cancer: Individual patient data meta-analysis prospects to personalized immunotherapy	6
Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinoma	6
Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblastoma	6
Regorafenib induces NOX5-mediated endoplasmic reticulum stress and potentiates the anti-tumor activity of cisplatin in non-small cell lung cancer cells	6
Downregulation of MGMT expression by targeted editing of DNA methylation enhances temozolomide sensitivity in glioblastoma	6
Overcoming prostate cancer drug resistance with a novel organosilicon small molecule	6
Overexpression of the miR-17-92 cluster in colorectal adenoma organoids causes a carcinoma-like gene expression signature	6
MET inhibition downregulates DR4 expression in MET-amplified lung cancer cells with acquired resistance to EGFR inhibitors through suppressing AP-1-mediated transcription	6
Comprehensive genomic profiling of Finnish lung adenocarcinoma cohort reveals high clinical actionability and SMARCA4 altered tumors with variable histology and poor prognosis	6
KCTD1 is a new modulator of the KCASH family of Hedgehog suppressors	6
Interdisciplinary care of children with diffuse midline glioma	6
Tumor-associated tissue eosinophilia promotes angiogenesis and metastasis in head and neck squamous cell carcinoma	6
Utilizing feline oral squamous cell carcinoma patients to develop NQO1-targeted therapy	6
Amelioration of muscle wasting by gintonin in cancer cachexia	6
Notch3 signaling between myeloma cells and osteocytes in the tumor niche promotes tumor growth and bone destruction	6
Molecular subtypes based on CNVs related gene signatures identify candidate prognostic biomarkers in lung adenocarcinoma	6
Cerebrospinal Fluid biomarkers in pediatric brain tumors: A systematic review	5
The SRSF3-MBNL1-Acin1 circuit constitutes an emerging axis to lessen DNA fragmentation in colorectal cancer via an alternative splicing mechanism	5
Developing H3K27M mutant selective radiosensitization strategies in diffuse intrinsic pontine glioma	5
Myxoid glioneuronal tumor: Histopathologic, neuroradiologic, and molecular features in a single center series	5
On the origin of germ cell neoplasia in situ: Dedifferentiation of human adult Sertoli cells in cross talk with seminoma cells in vitro	5
Genomic landscape and evolution of arm aneuploidy in lung adenocarcinoma	5
DAB2IP modulates primary cilia formation associated with renal tumorigenesis	5
Activation of the CREB Coactivator CRTC2 by Aberrant Mitogen Signaling promotes oncogenic functions in HPV16 positive head and neck cancer	5
Spatial organization of heterogeneous immunotherapy target antigen expression in high-grade glioma	5
Early growth response-1 is a new substrate of the GSK3β-FBXW7 axis	5
Metabolic reprogramming by adenosine antagonism and implications in non-small cell lung cancer therapy	5
Neural network based ensemble model to predict radiation induced lymphopenia after concurrent chemo-radiotherapy for non-small cell lung cancer from two institutions	5
Leptomeningeal dissemination in pediatric brain tumors	5
Time-restricted feeding affects the fecal microbiome metabolome and its diurnal oscillations in lung cancer mice	5
Embryonic protein NODAL regulates the breast tumor microenvironment by reprogramming cancer-derived secretomes	5
Current state of pediatric neuro-oncology imaging, challenges and future directions	4
Transcriptional signatures underlying dynamic phenotypic switching and novel disease biomarkers in a linear cellular model of melanoma progression	4
Sustained experimental activation of FGF8/ERK in the developing chicken spinal cord models early events in ERK-mediated tumorigenesis	4
Two transition states of the glycogen shunt and two steady states of gene expression support metabolic flexibility and the Warburg effect in cancer	4
Suppression of tumor progression by thioredoxin-interacting protein-dependent adenosine 2B receptor degradation in a PLAG-treated Lewis lung carcinoma-1 model of non–small cell lung cancer	4
Innate immunity: Looking beyond T-cells in radiation and immunotherapy combinations	4
Heterogeneous expression of predictive biomarkers PD-L1 and TIGIT in non-mucinous lung adenocarcinoma and corresponding lymph node metastasis: A challenge for clinical biomarker testing	4
TCF7L2 silencing results in altered gene expression patterns accompanied by local genomic reorganization	4
ABBV-744 induces autophagy in gastric cancer cells by regulating PI3K/AKT/mTOR/p70S6k and MAPK signaling pathways	4
Adiponectin paradox as a therapeutic target of the cancer evolvability in aging	4
Checkpoint inhibitor responses can be regulated by the gut microbiota – A systematic review	4
Ex vivo isolation, expansion and bioengineering of CCR7+CD95-/or CD62L+CD45RA+ tumor infiltrating lymphocytes from acute myeloid leukemia patients’ bone marrow	4
Comprehensive profiling of EGFR mutation subtypes reveals genomic-clinical associations in non-small-cell lung cancer patients on first-generation EGFR inhibitors	4
Prognostic value of integrin αV expression and localization pattern in invasive breast carcinomas	4
Identification and characterization of circular RNAs as novel putative biomarkers to predict anti-PD-1 monotherapy response in metastatic melanoma patients – Knowledge from two independent internation	4
Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology	4
IGDQ motogenic peptide gradient induces directional cell migration through integrin (αv)β3 activation in MDA-MB-231 metastatic breast cancer cells	4
The circadian clock, aging and its implications in cancer	4
Targeting MYC in combination with epigenetic regulators induces synergistic anti-leukemic effects in MLLr leukemia and simultaneously improves immunity	4
The kinetics of blast clearance are associated with copy number alterations in childhood B-cell acute lymphoblastic leukemia	4
MLH1 mediates cytoprotective nucleophagy to resist 5-Fluorouracil-induced cell death in colorectal carcinoma	4
RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer	4
S-adenosylmethionine blocks tumorigenesis and with immune checkpoint inhibitor enhances anti-cancer efficacy against BRAF mutant and wildtype melanomas	4